--Street Color: Eli Lilly Appoints Gordon Brooks Interim CFO-March 2024-www.financetom.com

Business

--Street Color: Eli Lilly Appoints Gordon Brooks Interim CFO

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Street Color: Eli Lilly Appoints Gordon Brooks Interim CFO

Jul 10, 2024 6:44 AM

09:23 AM EDT, 07/10/2024 (MT Newswires) --

Price: 938.75, Change: +6.25, Percent Change: +0.67

Previous page： Vishay Intertechnology Fiscal Q3 Adjusted Earnings, Revenue Decline; Q4 Outlook Issued Next page： Kits Eyecare Q3 Earnings Miss Expectations, But Revs Beat; Also Flags Revs Beat In Q4

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Vishay Intertechnology Fiscal Q3 Adjusted Earnings, Revenue Decline; Q4 Outlook Issued

Nov 6, 2024

08:39 AM EST, 11/06/2024 (MT Newswires) -- Vishay Intertechnology ( VSH ) reported fiscal Q3 adjusted earnings Wednesday of $0.08 per diluted share, down from $0.60 a year earlier. Three analysts polled by Capital IQ expected $0.14. Revenue for the fiscal quarter ended Sept. 28 was $735.4 million, down from $853.7 million a year earlier. Three analysts surveyed by Capital...

Kits Eyecare Q3 Earnings Miss Expectations, But Revs Beat; Also Flags Revs Beat In Q4

Nov 6, 2024

08:34 AM EST, 11/06/2024 (MT Newswires) -- Kits Eyecare ( KTYCF ) reported Wednesday a slight earnings miss for the third quarter, even as revenues beat expectations, and the company flagged higher than expected revenues for the fourth quarter. The company recorded third quarter net earnings of $0.132 million, or $0.00 per share, down from near $0.5 million, or $0.02...

Macerich Q3 FFO Declines, Revenue Rises; Appoints New Finance Chief

Nov 6, 2024

08:45 AM EST, 11/06/2024 (MT Newswires) -- Macerich ( MAC ) reported Q3 funds from operations Wednesday of $0.36 per diluted share, down from $0.41 a year earlier. Analysts polled by Capital IQ expected $0.39. Revenue for the quarter ended Sept. 30 was $203.4 million, up from $197.3 million a year earlier. Analysts polled by Capital IQ expected $206.1 million....

Cellebrite DI Q3 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Outlook Boosted

Nov 6, 2024

08:33 AM EST, 11/06/2024 (MT Newswires) -- Cellebrite DI ( CLBT ) reported Q3 Non-GAAP earnings Wednesday of $0.14 per diluted share, up from $0.09 a year earlier. Analysts polled by Capital IQ expected $0.09. Total revenue for the quarter ended Sept. 30 was $106.9 million, up from $84.2 million a year earlier. Analysts surveyed by Capital IQ expected $102.1...

About

Terms and Conditions Privacy policy Cookie Settings Contact Us

Services

financetom Market Personal Finance Business Economy Cryptocurrency MAP